Sam Holliday
Chief Executive Officer at Oshi Health, Inc.
Profile
Sam Holliday is currently the Chief Executive Officer at Oshi Health, Inc. He previously worked as the Vice President-Prime Research at Greenway Health, Inc. He received an undergraduate degree and an MBA from the University of Pennsylvania.
Sam Holliday active positions
| Companies | Position | Start |
|---|---|---|
Oshi Health, Inc.
 Oshi Health, Inc. Packaged SoftwareTechnology Services Oshi Health, Inc. engages in the provision of management and treatment of inflammatory bowel disease. It offers an IBD tracking application that uncovers the hidden patterns that allows to figure out what triggers the flares. The company was founded in 2018 and is headquartered in New York, NY. | Chief Executive Officer | 01/12/2019 |
Former positions of Sam Holliday
| Companies | Position | End |
|---|---|---|
Greenway Health, Inc.
 Greenway Health, Inc. Information Technology ServicesTechnology Services Greenway Health, Inc. provides technical solutions and services for healthcare customers. It offers electronic healthcare record, practice management, and clearinghouse services. The company was founded by Thomas W. Green Jr. in 1989 and is headquartered in Tampa, FL. | Corporate Officer/Principal | - |
Training of Sam Holliday
| University of Pennsylvania | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Greenway Health, Inc.
Greenway Health, Inc. Information Technology ServicesTechnology Services Greenway Health, Inc. provides technical solutions and services for healthcare customers. It offers electronic healthcare record, practice management, and clearinghouse services. The company was founded by Thomas W. Green Jr. in 1989 and is headquartered in Tampa, FL. | Technology Services |
Oshi Health, Inc.
Oshi Health, Inc. Packaged SoftwareTechnology Services Oshi Health, Inc. engages in the provision of management and treatment of inflammatory bowel disease. It offers an IBD tracking application that uncovers the hidden patterns that allows to figure out what triggers the flares. The company was founded in 2018 and is headquartered in New York, NY. | Technology Services |
- Stock Market
- Insiders
- Sam Holliday
